Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2009Journal of Clinical OncologyOpen Access

2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

JTJulie TinatCentre Hospitalier Universitaire de BordeauxGBGaëlle BougeardInsermSBStéphanie Baert‐DesurmontInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tinat et al. (2009) studied this question.

synapsesocial.com/papers/6a77ddb50c6965f1a01efb11https://doi.org/10.1200/jco.2009.22.7967
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sensitivity and predictive value of criteria for p53germline mutation screening2001 · 346 citations
  2. 2Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations2009 · 612 citations
  3. 3Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS families2008 · 231 citations
  4. 4Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome1999 · 909 citations
  5. 5Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms1990 · 3,801 citations